DK0538496T3 - Rekombinant fjerkrækoppevirus med intakt FPV tk-gen - Google Patents

Rekombinant fjerkrækoppevirus med intakt FPV tk-gen

Info

Publication number
DK0538496T3
DK0538496T3 DK91114300T DK91114300T DK0538496T3 DK 0538496 T3 DK0538496 T3 DK 0538496T3 DK 91114300 T DK91114300 T DK 91114300T DK 91114300 T DK91114300 T DK 91114300T DK 0538496 T3 DK0538496 T3 DK 0538496T3
Authority
DK
Denmark
Prior art keywords
fpv
gene
intergenic region
intact
recombinant
Prior art date
Application number
DK91114300T
Other languages
English (en)
Inventor
Friedrich Dipl-In Scheiflinger
Friedrich Prof Dr Dorner
Falko Guenter Dr Falkner
Original Assignee
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare Sa filed Critical Baxter Healthcare Sa
Application granted granted Critical
Publication of DK0538496T3 publication Critical patent/DK0538496T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91114300T 1991-08-26 1991-08-26 Rekombinant fjerkrækoppevirus med intakt FPV tk-gen DK0538496T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91114300A EP0538496B1 (en) 1991-08-26 1991-08-26 Recombinant fowlpox virus with intact FPV-tk-gene

Publications (1)

Publication Number Publication Date
DK0538496T3 true DK0538496T3 (da) 2004-02-23

Family

ID=8207076

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91114300T DK0538496T3 (da) 1991-08-26 1991-08-26 Rekombinant fjerkrækoppevirus med intakt FPV tk-gen

Country Status (12)

Country Link
US (1) US5670367A (da)
EP (2) EP0538496B1 (da)
JP (1) JP2703853B2 (da)
AT (1) ATE253123T1 (da)
AU (1) AU661488B2 (da)
CA (1) CA2076903A1 (da)
CZ (1) CZ264092A3 (da)
DE (1) DE69133333T2 (da)
DK (1) DK0538496T3 (da)
ES (1) ES2212795T3 (da)
HU (1) HUT62653A (da)
SK (1) SK264092A3 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955652A (en) * 1992-06-16 1999-09-21 The Trustees Of The University Of Pennsylvania Plant genes for sensitivity to ethylene and pathogens
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
AU6299594A (en) * 1993-02-26 1994-09-14 Nippon Zeon Co., Ltd. Recombinant fowlpox virus s-fpv-043 and uses thereof
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
US5821059A (en) * 1993-08-06 1998-10-13 Iowa State University Research Foundation, Inc. Mycoplasma expression system
ATE298370T1 (de) * 1994-04-29 2005-07-15 Baxter Healthcare Sa Rekombinante poxviren mit fremdenpolynukleotiden in wichtigen regionen
EP0753581A1 (en) 1995-07-10 1997-01-15 Immuno Ag Improved recombinant eukaryotic cytoplasmic viruses, method for their production and their use as vaccines
US6534631B1 (en) 1998-07-15 2003-03-18 Human Genome Sciences, Inc. Secreted protein HT5GJ57
AU6518298A (en) * 1997-03-28 1998-10-22 Nippon Zeon Co., Ltd. Novel dna vector and vaccines containing novel recombinant dna vectors as the active ingredient
US20070014787A1 (en) 1998-07-15 2007-01-18 Human Genome Sciences, Inc. 71 human secreted proteins
US7091315B1 (en) 1998-07-15 2006-08-15 Human Genome Sciences, Inc. Protein HDPBQ71
EP1097199A4 (en) * 1998-07-15 2005-02-23 Human Genome Sciences Inc 71 HUMAN SECRETED PROTEINS
US6872811B1 (en) * 1998-09-30 2005-03-29 Millennium Pharmaceuticals, Inc. HRPCa9 and HRPCa10 nucleic acids and polypeptides
EP2388015A1 (en) 2000-03-02 2011-11-23 Emory University DNA expression vectors and methods of use
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
EP1268761B1 (en) * 2000-03-24 2008-12-31 Cell Genesys, Inc. Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof
GB0014288D0 (en) * 2000-06-10 2000-08-02 Smithkline Beecham Biolog Vaccine
AU2001283042A1 (en) * 2000-07-29 2002-02-13 Genaissance Pharmaceuticals, Inc. Haplotypes of the il12b gene
WO2002020808A1 (fr) * 2000-09-04 2002-03-14 House Foods Corporation Isozymes de synthase de composant lacrymogene et gene les codant
EP1379549A2 (fr) * 2001-02-07 2004-01-14 Institut Pasteur Sequence du genome de photorhabdus luminescens souche tto1 et utilisations
JP4554887B2 (ja) * 2001-03-08 2010-09-29 アメリカ合衆国 改変ＨＩＶエンベロープ、ｇａｇ、およびｐｏｌ遺伝子を発現するＭＶＡ
EP1483396A4 (en) * 2001-06-12 2005-09-28 Univ California NEW GENE WIT 3.0, FOR HEALING OF LESIONS IN SOFT TISSUE
ATE315660T1 (de) 2002-05-16 2006-02-15 Bavarian Nordic As Intergene regionen als insertionsstellen im genom von modifiziertem vaccinia virus ankara (mva)
US7056733B2 (en) * 2003-02-19 2006-06-06 University Of Kentucky Research Foundation Nucleic acids encoding Sarcocystis neurona antigen and uses thereof
EP2363493B1 (en) * 2003-02-20 2012-11-14 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Novel insertion sites in pox vectors
US20070003520A1 (en) 2003-11-17 2007-01-04 Brown Susanne M Mutant viruses
GB0326798D0 (en) 2003-11-17 2003-12-24 Crusade Lab Ltd Methods for generating mutant virus
US7897146B2 (en) 2003-11-17 2011-03-01 Crusade Laboratories Limited Treatment using herpes simplex virus
JP4271122B2 (ja) * 2004-10-15 2009-06-03 財団法人 ひろしま産業振興機構 カイコでの組換えタンパク質製造のためのポリヌクレオチド
US20060090646A1 (en) * 2004-11-04 2006-05-04 Questair Technologies Inc. Adsorbent material for selective adsorption of carbon monoxide and unsaturated hydrocarbons
US7807180B2 (en) * 2007-08-21 2010-10-05 University Of Massachusetts Poxvirus methods and compositions
US8314228B2 (en) * 2009-02-13 2012-11-20 Aurora Algae, Inc. Bidirectional promoters in Nannochloropsis
WO2011041789A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus immunogenic compositions
US9839684B2 (en) 2011-04-06 2017-12-12 Biovaxim Limited Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance
AU2012381062B2 (en) * 2012-06-01 2016-02-18 Exxonmobil Research And Engineering Company Promoters and terminators for use in eukaryotic cells
US10612034B2 (en) 2012-06-01 2020-04-07 Exxonmobil Research And Engineering Company Promoters and terminators for use in eukaryotic cells
US8883993B2 (en) 2012-12-04 2014-11-11 Exxonmobil Research And Engineering Company Tetraselmis promoters and terminators for use in eukaryotic cells
ES2901468T3 (es) * 2015-07-31 2022-03-22 Bavarian Nordic As Promotores para mejorar la expresión en poxvirus
WO2017120577A1 (en) 2016-01-08 2017-07-13 Geovax Inc. Compositions and methods for generating an immune response to a tumor associated antigen
US11311612B2 (en) 2017-09-19 2022-04-26 Geovax, Inc. Compositions and methods for generating an immune response to treat or prevent malaria
EP4103231A4 (en) 2020-02-14 2024-03-27 Geovax, Inc. VACCINES AND THEIR USES TO INDUCE AN IMMUNE RESPONSE AGAINST SARS-COV2

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338683A (en) * 1981-12-24 1994-08-16 Health Research Incorporated Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
US5174993A (en) * 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
JPH082307B2 (ja) * 1984-05-22 1996-01-17 トランスジ−ン ソシエテ アノニム 第▲ｉｘ▼因子の製造方法
WO1986005806A1 (en) * 1985-03-29 1986-10-09 National Research Development Corporation Infectious bronchitis virus spike protein
US4713004A (en) * 1986-09-04 1987-12-15 Vent Plant Corporation Submergible screw-type dental implant and method of utilization
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
AU605567B2 (en) * 1987-03-11 1991-01-17 Nippon Zeon Co., Ltd. Recombinant avipoxvirus
DE10399032I1 (de) * 1987-08-28 2004-01-29 Health Research Inc Rekombinante Viren.
CA1340203C (en) * 1987-09-16 1998-12-15 Noboru Yanagida Recombinant apivoxvirus
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
DE3813093A1 (de) * 1988-04-19 1989-11-09 Immuno Ag Rekombinantes plasmid, verfahren zum herstellen eines rekombinanten avipoxvirus, rekombinantes avipoxvirus und dessen verwendung
JP2538367B2 (ja) * 1988-06-24 1996-09-25 ブリティッシュ・テクノロジー・グループ・リミテッド Ｆｏｗｌｐｏｘウィルスの非必須領域
US5093258A (en) * 1988-08-26 1992-03-03 Therion Biologics Corporation Recombinant fowlpox virus and recombination vector
CA2001001A1 (en) * 1988-10-21 1990-04-21 Matthew M. Binns Fowlpox virus promoter

Also Published As

Publication number Publication date
HU9202753D0 (en) 1993-05-28
US5670367A (en) 1997-09-23
DE69133333D1 (de) 2003-12-04
AU1958092A (en) 1993-03-04
EP0538496A1 (en) 1993-04-28
DE69133333T2 (de) 2004-07-29
HUT62653A (en) 1993-05-28
SK264092A3 (en) 1995-07-11
JP2703853B2 (ja) 1998-01-26
EP0538496B1 (en) 2003-10-29
AU661488B2 (en) 1995-07-27
JPH05192165A (ja) 1993-08-03
CA2076903A1 (en) 1993-02-27
CZ264092A3 (en) 1993-03-17
ES2212795T3 (es) 2004-08-01
EP1380651A2 (en) 2004-01-14
ATE253123T1 (de) 2003-11-15

Similar Documents

Publication Publication Date Title
DK0538496T3 (da) Rekombinant fjerkrækoppevirus med intakt FPV tk-gen
FI107610B (fi) HCV-fuusioproteiini
ATE79649T1 (de) Herpes simplex-virus als vektor.
PT574048E (pt) Peptidos e sequencias de acido nucleico relacionados com virus de epstein-barr
ATE284954T1 (de) Hyaluronan synthase gen und seine verwendung
DE69535359D1 (de) Rekombinantes herpesvirus aus trufhähnen und seine verwendungen
ES2172502T3 (es) Receptores tipo ii de interleucina 1.
DK0707071T3 (da) Rekombinante vektorer afledt fra adenovirus til anvendelse i genterapi
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
ATE73348T1 (de) Thymidinkinase-deletionsmutanten von bovinem herpesvirus-1, diese enthaltende impfstoffe gegen bovine rhinotracheitis und verfahren zu deren herstellung und verwendung.
MX9202512A (es) Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus.
DE69214146D1 (de) Deletionsmutanten von bovinem herpuvirus-1, auf diese basierte impfstoffe,diagnosesätze für den nachweis von bovinem herpesvirus-1
ATE233821T1 (de) Poxvirusvektoren und deren anwendung als impstoff gegen katzenansteckende peritonitis- viruskrankheit
PT83968B (pt) Processo para melhoramento da expressao de proteina eucariotica, de preparacao de um plasmideo e plasmideo
ATE243755T1 (de) Rekombinente adenoviren-impfstoffe
DE3852870D1 (de) Saurer Fibroblast-Wachstumsfaktor-Mutant.
ATE100495T1 (de) Rekombinantes marek-krankheitsvirus, verfahren zu seiner herstellung, und vakzine.
DK498387A (da) Virus-dna-sekvens
EP0676413A3 (en) Interferon alpha / beta binding protein, its production and application.
RU93018105A (ru) Штамм рекомбинантного вируса осповакцины, вызывающий иммунитет против вируса венесуэльского энцефаломиелита лошадей в организме животных, и способ его получения
Landolfi et al. Molecular weight diversity among murine class I antigens: both the mature cell surface forms and the unglycosylated polypeptides vary significantly in molecular weight
SE9403613D0 (sv) Improvement of an expression vector for production of recombinant proteins
Hjalmarsson 2.7. Properdin factor B (Bf) polymorphism in Sweden
SU1380209A1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ
ATE368102T1 (de) Dna-fpr-expression von alpha-i-antitrypsin in methylotropher hefe